The pharmacological treatment of Menière's disease.
The management of Menière's disease often provides a formidable clinical challenge largely because its precise aetiology is unknown. There is no known 'cure' once the condition is established, but drugs may be helpful in treating both the acute attacks of vertigo, and in more long-term management, particularly in the earlier fluctuant stage. These remedies are largely symptomatic and there are few if any properly controlled studies of their efficacy. Suppressant drugs may act centrally at neurotransmitter sites, or peripherally on the labyrinth. Conventional diuretics and osmotically acting agents have been given to reduce the endolymph fluid volume. Histamine analogues directly reduce inner ear fluid pressure mainly by increasing the cochlear blood flow, and are probably the treatment of choice. Otovestibulotoxic drugs given systemically to cause chemical labyrinthine ablation are frequently effective in abolishing attacks of vertigo but often resulted in disabling oscillopsia and ataxia. There is now evidence that local administration by intratympanic injection may well be more efficacious resulting in selective partial end organ ablation. To date innovative immune modifying regimes have not proved helpful.
Brookes
G B
GB
Royal National Throat, Nose and Ear Hospital, National Hospital for Neurology and Neurosurgery, London, UK.
D000617:Aminoglycosides / Q000009:adverse effects / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D007758:Ear, Inner / Q000503:physiopathology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008575:Meniere Disease / Q000150:complications / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014717:Vertigo / Q000150:complications / Q000503:physiopathology
D000617:Aminoglycosides; D000932:Antiemetics; D018680:Cholinergic Antagonists; D006993:Hypnotics and Sedatives; D014665:Vasodilator Agents